SLC22A7 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC) patients who were treated with local ablation therapy, patients with lower OAT2 expression in the liver exhibited increased rates of multifocal recurrence than those having a normal expression level of OAT2.